Novo Nordisk results beat expectations, but shares fall on Copenhagen stock exchange
The reactions to Novo Nordisk's interim report dragged the entire Copenhagen stock exchange down on Wednesday. But pharmaceutical analyst Johan Unnerus believes that the pharmaceutical giant is a positive surprise. They are clearly delivering above expectations in terms of profitability and in diabetes, he says.
Business